NCT03793075

Brief Summary

Host systemic responses to vigorous stimuli as trauma, surgical tissue injury, anesthesia and post-operative pain, leads to release a variety of pro-inflammatory cytokines including interleukin-1 (IL-1) and interleukin-6 (IL-6) mainly from monocytes and macrophages Thus, the rise of IL-6 is regarded as an early marker of tissue damage and its rise proportional to the degree of tissue damage . It has been demonstrated that systemic responses to stress may be modified by the anesthetic technique used . Total intravenous anesthesia (TIVA) especially propofol based greatly suppresses the stress response induced by surgery when compared to inhalation by lowering cortisol levels. Ketamine has the ability to modulate (modify) inflammation . Even the sub-anesthetic doses of ketamine in animal models were even provided to have an effect on the inflammatory response system in the central nervous system

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 4, 2019

Completed
6 days until next milestone

Study Start

First participant enrolled

January 10, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2019

Completed
Last Updated

January 7, 2019

Status Verified

January 1, 2019

Enrollment Period

5 months

First QC Date

December 30, 2018

Last Update Submit

January 3, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • Serum level of interleukin 6 (IL-6)

    picogram/milliliter using ELISA techniques .Five measurement points : before the induction of general anesthesia, 30 min after beginning infusion of the anesthetic agent , then 2h, 8h and 24 hours postoperative.

    The time frame extend from 10 minutes before the induction of anesthesia till the first 24 hours postoperative

  • Serum level of interleukin IL-1β (IL-1β)

    picogram/milliliter using ELSA techniques .Five measurement points : before the induction of general anesthesia, 30 min after beginning infusion of the anesthetic agent , then 2h, 8h and 24 hours postoperative.

    The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative

Secondary Outcomes (5)

  • Absolute neutrophil count

    The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative

  • Total leukocyte count

    The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative

  • Neutrophil-lymphocyte ratio (N/L ratio)

    The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative

  • Serum Cortisol level

    The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative

  • C-reactive protein serum level

    The time frame extend from 10 minutes before induction of anesthesia till the first 24 hours postoperative

Study Arms (2)

Propofol group (P)

PLACEBO COMPARATOR

The maintenance of anesthesia , patient will receive sevoflurane 1%-2.5% with intravenous infusion of propofol 17 mcg /kg/min and 0.5 mg/kg fentanyl will be given if the heart rate or mean blood pressure increased by 30 % or more from the basal readings

Drug: Propofol

Ketamine group ((K)

ACTIVE COMPARATOR

The maintenance of anesthesia , patient will receive sevoflurane 1%-2.5% with intravenous infusion of ketamine 5 mcg /kg/min and 0.5 mg/kg fentanyl will be given if the heart rate or mean blood pressure increased by 30 % or more from the basal readings

Drug: Ketamine

Interventions

ketamine 5 mcg/kg/min will be used as intravenous anesthetic infusion

Also known as: ketalar
Ketamine group ((K)

propofol 17 mcg /kg/min

Also known as: diprivan
Propofol group (P)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective major abdominal surgeries with median incision with right or left extension.
  • ASA -physical status I -II
  • aged from 18 till 70 years

You may not qualify if:

  • body mass index more than 35 kg/m2,
  • Patients having severe cardiovascular, respiratory, hepatic, renal, Endocrinol disorders, malignant
  • Patients having chronic inflammatory diseases
  • Patients received suppressant drugs in the 6 weeks before surgery.
  • Any known allergy or any contraindications to anesthetic drugs;
  • patient refusal,
  • The usage of anti- emetic drug 24 hours before operation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

KetaminePropofol

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPhenolsBenzene DerivativesHydrocarbons, Aromatic

Study Officials

  • Reem Abdelraouf, lecturer

    Mansoura University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Reem Abdelraouf, lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Double -blinded ( masking of both participant and care provider)
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participating subject will be divided equally and randomly into two groups.The first group is propofol group while the second is the ketamine group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of anesthesia and surgical intensive care

Study Record Dates

First Submitted

December 30, 2018

First Posted

January 4, 2019

Study Start

January 10, 2019

Primary Completion

June 1, 2019

Study Completion

August 15, 2019

Last Updated

January 7, 2019

Record last verified: 2019-01